INS and obesity disorder: The reduction innutrients appears to inhibit the insulin and nutrient-sensing target ofrapamycin (TOR) protein signaling pathway [152], whereas obesity activates it,elevating diseases that accompany the metabolic syndrome, such as diabetes, atherosclerosisand dementia.